Moderna released its final data on its coronavirus vaccine on Monday, saying its candidate has proven to be nearly 94.1 per cent effective in protecting people from the disease.The pharmaceutical company also said the vaccine had an efficacy rate of 100 per cent against severe coronavirus cases.Moderna on Monday plans to request an emergency use authorization from the U.S.
Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA). A coronavirus vaccine is almost ready.
But will you take it? The Phase 3 trial data showed the vaccine is “generally well tolerated” and there are no serious safety concerns identified to date, the company said in a press release.